MYC-driven HCC cells exhibited decreased ATP levels in response to the inhibition of XPO1 and PRMT5 and fibroblasts were less sensitive towards XPO1 and PRMT5 inhibition than MYC-driven HCC cells (Supplementary Fig. 7a, b). The gene discussed is PRMT5; the disease is hepatocellular carcinoma.